>AT1G78300.1 | GRF2 (GENERAL REGULATORY FACTOR 2) protein binding / protein phosphorylated amino acid binding
MASGREEFVYMAKLAEQAERYEEMVEFMEKVSAAVDGDELTVEERNLLSVAYKNVIGARR
ASWRIISSIEQKEESRGNDDHVTAIREYRSKIETELSGICDGILKLLDSRLIPAAASGDS
KVFYLKMKGDYHRYLAEFKTGQERKDAAEHTLAAYKSAQDIANAELAPTHPIRLGLALNF
SVFYYEILNSPDRACNLAKQAFDEAIAELDTLGEESYKDSTLIMQLLRDNLTLWTSDMQD
DAADEIKEAAAPKPTEEQQ*
>AT5G48400.1 | ATGLR12 intracellular ligand-gated ion channel
MVRICIQTPILLSFLLVLLFFISNCFASSQNNDDDKRIRVRVGLVLDLGSVEGKIVRSSV
SMALSDFYDNHNDYKTRLSLLVRDSHGEPLLALDSVVDLLQTEGVQAIIGGNSLLEAKLL
AELGEKARVPVISLNSPMSLSLSKYTHLIQATHNSASEVKGITAFLHGFDWNSVALVLED
HDDWRESMHFMVDHFHENNVHVQSKVAFSVTSSEDSLMDRLRELKDLGTTVFVVHLSEVI
ATRLFPCAEKLGMMGEGFAWILTSRSMSSFHDQFIDDLTKEAMEGVVGFKSYIPMSKELH
NFTLRWRKTLPVEEVTGSEITRLSISGVWAHDVAWSLASAAEVTRMPTVTSTLLEAIKES
RFKGLSGNFQLDDMKLLSDKFEIVNMIGSGERRVGFWNSNGSFSNRRQLSSTHDNLETII
WPGGSAQSPKGRSLRESGRKKLRVLVTSSNRFPRLMKVETDPITHEITIVEGFCIEVFQA
SIAPFNYEVEYIRWLNGTNYTKLAYALHSQKDKYDAAVGDITITSDRSMYVDFTLPYTEM
GLGIVAAKERSMWVFFQPLTPNLWITSAAFFVLTGIIVWLIERAENKEFQGSWPQQIGVV
IWFGFSTLVYAHREKLQHNLSRFVVTVWVFAVLILVTSYTATLTSMMTVQQIRFNANEDY
VGHLSGSLIANAALTNSSLRAMRLLGLNTSEDYAQALMNKSVSYIVSELPYLKILLGENP
GHFLMVKTQSTTNGFGFVCILLLHHQLLYS*
>AT5G48400.1 | ATGLR12 intracellular ligand-gated ion channel
MVRICIQTPILLSFLLVLLFFISNCFASSQNNDDDKRIRVRVGLVLDLGSVEGKIVRSSV
SMALSDFYDNHNDYKTRLSLLVRDSHGEPLLALDSVVDLLQTEGVQAIIGGNSLLEAKLL
AELGEKARVPVISLNSPMSLSLSKYTHLIQATHNSASEVKGITAFLHGFDWNSVALVLED
HDDWRESMHFMVDHFHENNVHVQSKVAFSVTSSEDSLMDRLRELKDLGTTVFVVHLSEVI
ATRLFPCAEKLGMMGEGFAWILTSRSMSSFHDQFIDDLTKEAMEGVVGFKSYIPMSKELH
NFTLRWRKTLPVEEVTGSEITRLSISGVWAHDVAWSLASAAEVTRMPTVTSTLLEAIKES
RFKGLSGNFQLDDMKLLSDKFEIVNMIGSGERRVGFWNSNGSFSNRRQLSSTHDNLETII
WPGGSAQSPKGRSLRESGRKKLRVLVTSSNRFPRLMKVETDPITHEITIVEGFCIEVFQA
SIAPFNYEVEYIRWLNGTNYTKLAYALHSQKDKYDAAVGDITITSDRSMYVDFTLPYTEM
GLGIVAAKERSMWVFFQPLTPNLWITSAAFFVLTGIIVWLIERAENKEFQGSWPQQIGVV
IWFGFSTLVYAHREKLQHNLSRFVVTVWVFAVLILVTSYTATLTSMMTVQQIRFNANEDY
VGHLSGSLIANAALTNSSLRAMRLLGLNTSEDYAQALMNKSVSYIVSELPYLKILLGENP
GHFLMVKTQSTTNGFGFVCILLLHHQLLYS*
>AT5G48400.2 | ATGLR12 intracellular ligand-gated ion channel
MVRICIQTPILLSFLLVLLFFISNCFASSQNNDDDKRIRVRVGLVLDLGSVEGKIVRSSV
SMALSDFYDNHNDYKTRLSLLVRDSHGEPLLALDSVVDLLQTEGVQAIIGGNSLLEAKLL
AELGEKARVPVISLNSPMSLSLSKYTHLIQATHNSASEVKGITAFLHGFDWNSVALVLED
HDDWRESMHFMVDHFHENNVHVQSKVAFSVTSSEDSLMDRLRELKDLGTTVFVVHLSEVI
ATRLFPCAEKLGMMGEGFAWILTSRSMSSFHDQFIDDLTKEAMEGVVGFKSYIPMSKELH
NFTLRWRKTLPVEEVTGSEITRLSISGVWAHDVAWSLASAAEVTRMPTVTSTLLEAIKES
RFKGLSGNFQLDDMKLLSDKFEIVNMIGSGERRVGFWNSNGSFSNRRQLSSTHDNLETII
WPGGSAQSPKGRSLRESGRKKLRVLVTSSNRFPRLMKVETDPITHEITIVEGFCIEVFQA
SIAPFNYEVEYIRWLNGTNYTKLAYALHSQKDKYDAAVGDITITSDRSMYVDFTLPYTEM
GLGIVAAKERSMWVFFQPLTPNLWITSAAFFVLTGIIVWLIERAENKEFQGSWPQQIGVV
IWFGFSTLVYAHREKLQHNLSRFVVTVWVFAVLILVTSYTATLTSMMTVQQIRFNANEDY
VGHLSGSLIANAALTNSSLRAMRLLGLNTSEDYAQALMNKSVSYIVSELPYLKILLGENP
GHFLMVKTQSTTNGFGFMFQKGSELAPNVSREIAKLRTSERLNEMERRWFDKQLPYTTDD
TSNPITLYRFRGLFMITGVSFAFALAVLLILWLRERWEILVNSVNIYFSQRLRHFRILFT
RTIHPSPLGLDNPIGENAVQMAQRNRR*
>AT5G48400.2 | ATGLR12 intracellular ligand-gated ion channel
MVRICIQTPILLSFLLVLLFFISNCFASSQNNDDDKRIRVRVGLVLDLGSVEGKIVRSSV
SMALSDFYDNHNDYKTRLSLLVRDSHGEPLLALDSVVDLLQTEGVQAIIGGNSLLEAKLL
AELGEKARVPVISLNSPMSLSLSKYTHLIQATHNSASEVKGITAFLHGFDWNSVALVLED
HDDWRESMHFMVDHFHENNVHVQSKVAFSVTSSEDSLMDRLRELKDLGTTVFVVHLSEVI
ATRLFPCAEKLGMMGEGFAWILTSRSMSSFHDQFIDDLTKEAMEGVVGFKSYIPMSKELH
NFTLRWRKTLPVEEVTGSEITRLSISGVWAHDVAWSLASAAEVTRMPTVTSTLLEAIKES
RFKGLSGNFQLDDMKLLSDKFEIVNMIGSGERRVGFWNSNGSFSNRRQLSSTHDNLETII
WPGGSAQSPKGRSLRESGRKKLRVLVTSSNRFPRLMKVETDPITHEITIVEGFCIEVFQA
SIAPFNYEVEYIRWLNGTNYTKLAYALHSQKDKYDAAVGDITITSDRSMYVDFTLPYTEM
GLGIVAAKERSMWVFFQPLTPNLWITSAAFFVLTGIIVWLIERAENKEFQGSWPQQIGVV
IWFGFSTLVYAHREKLQHNLSRFVVTVWVFAVLILVTSYTATLTSMMTVQQIRFNANEDY
VGHLSGSLIANAALTNSSLRAMRLLGLNTSEDYAQALMNKSVSYIVSELPYLKILLGENP
GHFLMVKTQSTTNGFGFMFQKGSELAPNVSREIAKLRTSERLNEMERRWFDKQLPYTTDD
TSNPITLYRFRGLFMITGVSFAFALAVLLILWLRERWEILVNSVNIYFSQRLRHFRILFT
RTIHPSPLGLDNPIGENAVQMAQRNRR*
>AT3G04110.1 | GLR11 (GLUTAMATE RECEPTOR 11) cation channel/ intracellular ligand-gated ion channel
MEILFSISILALLFSGVVAAPSDDDVFEEVRVGLVVDLSSIQGKILETSFNLALSDFYGI
NNGYRTRVSVLVRDSQGDPIIALAAATDLLKNAKAEAIVGAQSLQEAKLLATISEKAKVP
VISTFLPNTLSLKKYDNFIQWTHDTTSEAKGITSLIQDFSCKSVVVIYEDADDWSESLQI
LVENFQDKGIYIARSASFAVSSSGENHMMNQLRKLKVSRASVFVVHMSEILVSRLFQCVE
KLGLMEEAFAWILTARTMNYLEHFAITRSMQGVIGFKSYIPVSEEVKNFTSRLRKRMGDD
TETEHSSVIIGLRAHDIACILANAVEKFSVSGKVEASSNVSADLLDTIRHSRFKGLSGDI
QISDNKFISETFEIVNIGREKQRRIGLWSGGSFSQRRQIVWPGRSRKIPRHRVLAEKGEK
KVLRVLVTAGNKVPHLVSVRPDPETGVNTVSGFCVEVFKTCIAPFNYELEFIPYRGNNDN
LAYLLSTQRDKYDAAVGDITITSNRSLYVDFTLPYTDIGIGILTVKKKSQGMWTFFDPFE
KSLWLASGAFFVLTGIVVWLVERSVNPEFQGSWGQQLSMMLWFGFSTIVFAHREKLQKMS
SRFLVIVWVFVVLILTSSYSANLTSTKTISRMQLNHQMVFGGSTTSMTAKLGSINAVEAY
AQLLRDGTLNHVINEIPYLSILIGNYPNDFVMTDRVTNTNGFGFMFQKGSDLVPKVSREI
AKLRSLGMLKDMEKKWFQKLDSLNVHSNTEEVASTNDDDEASKRFTFRELRGLFIIAGAA
HVLVLALHLFHTRQEVSRLCTKLQSFYK*
>AT3G07520.1 | GLR14 (GLUTAMATE RECEPTOR 14) cation channel/ intracellular ligand-gated ion channel
MENCMIRNTGYFLTIFFLAFISFAVTCSGTNQKDNVDRLPVVYEDVRIGLVVDMGSMEGK
LVTTSISMALSDFYHVNNGYRTRVSVLSRDSHGDPLQALAAAMDLLQTEQVEALVGGQSL
LEAKNLAELGEKTKVPVISSFQVPSSLSLAKYNYFIQATHDTSSEAKGIAALFSNFDWRT
AVLIYEDDDDWRESIQPLVGHFQQNAIHIEYKAEFSVSSNEECIMKQLRKFKASGIRIFV
AHISERIANRLFPCARRLGMMEEGYAWILTARSMNNFQDTNYLAKEEMEGVIGFKSYIPL
TEELHNFTLRWKRSLRLEEVVTRMSVCSIWAHDIAWSLARAAEVAKLPGLSVYDLLEAIP
ESAKHKGLSGDIKFIDKKFISDKFEIVNMIGRGERSVGLWNSGSFISNRRRRLSSTKALE
TIIWPGGSTRIPKIRSLKEKRHGKKKKLRVLVPAGNITPQILEVKTDFKTGVTAATGYCI
DVFETSILPFNYEVEYIPWPGAINYKNYNDLVYTLYSQKDKYDAAVGDITITDNRSLYVD
FTLPFTDMGLAVVTAKDKSMWIIFKPLTLSLWLTIASFFILTGAIVWLIERHDNADFQGS
CFQQIGTLLCFGFSTLVFAHRERLQHNMSRFVVIVWIFAVLILTSNYTATLTSVMTVQQI
RGLKSNENIGFFSASIAANVVNDNPTFQGPRYKGLKTADDFTNALRNGTISFIVDEVPYV
KLFVAKHPSEFVIVETESVTNGFGFAFQKGSPLVQKVSREIEKLRRTEKLKAIENWWFQR
QTTSATSEDTFHPLTVYTFRGLFMITGVSFAFALIVYLIPWNREQRQVVLKHFHRYVSHR
FAREIRPSPTTPNRQNENSVI*
>AT5G48410.1 | ATGLR13 intracellular ligand-gated ion channel
MERFCIQTQTLLSFLLVLLLFISRSFASTKNDDVDGGKRVQIRVGLVLDLGSLKGKIVKN
SVSMALSYFYAIHNDYKTRVSVSLRNSHGEPLLALASAVDLLKTEGVEAIIGGNSLLEAK
LLGELGEKARVPMISLDSPFSLSLSKYTHLIQATHDSTSEAKGITSFINVFDWNSVALVY
EDHDDWRESMQLLVEHFHENGVRVQSKVGFTVSSSEDFVMGRLQQLKDLGTTVFVVHLSE
VIATHLFPCARRLGLMGDGFVWILTAKTMNSFHENIDDFTKQAMEGVVGFKSYIPMSIEL
QNFTLRWRKSLPVEEAELTRLSISGIWAHDIAFALARAAEVIRMPNVTSTLLEEITKTRF
NGLSGDFQLNDKKLLSNKFEIINMIGSSERRVGFLNSNGSFSNRRHLSSTHNKLETIIWP
GGSAQSPKGTSLIDSDRKKLRVLVTSSNRFPRLMKVETDPVTNELIVEGFCIEVFRASIS
PFNYEVEYIPWLNGSNYDNLAYALHSQKDKYDAAVGDITITSNRSTYVDFTLPFTEMGLG
IVAVKERSMWVFFQPLTPDLWITSAFFFVLTGVIVWLIERAENKEFQGSWPQQIGVVLWF
GFSTLVYAHREKLKHNLSRFVVTVWVFAVLILTASYTATLTSMMTVQQIRFNSNEDYVGH
LSGSLIANVALTSSSLRAMRSLGLNSAADYAQALLNKTVSFVVDELPYLKVVLGENPTHF
FMVKTQSTTNGFGFMFQKGFELVPNVSREISKLRTSEKLNEMEKRWFDNQLPYTTDDTSN
PITLYRFRGLFIIIGVSFAFALAVLVILCLRDKWEILVDNLDLSQRLRHFRIHFVRSIHT
SPLDDPIGETAVQMAQQNRQ*
>AT2G39230.1 | pentatricopeptide (PPR) repeat-containing protein
MTTFMVSKRFRPPIFLHRFINPKPISSQTRFLHPPDNQSRDISDSTTETISTLEFPHKTS
VPNHSPLTSTSETENHVDDARVIEVLLGRRNDPVSALQYCNWVKPLHRLCEGGDVFWVLI
HILLSSIHTHDRASNLLVMFVSNNPTLIPNVMVNNLVDSSKRFGFELTPRAFNYLLNAYI
RNKRMDYAVDCFGLMVDRKVVPFVPYVNNVLSSLVRSNLIDEAKEIYNKMVLIGVAGDNV
TTQLLMRASLRERKPEEAVKIFRRVMSRGAEPDGLLFSLAVQAACKTPDLVMALDLLREM
RGKLGVPASQETYTSVIVAFVKEGNMEEAVRVMDEMVGFGIPMSVIAATSLVNGYCKGNE
LGKALDLFNRMEEEGLAPDKVMFSVMVEWFCKNMEMEKAIEFYMRMKSVRIAPSSVLVHT
MIQGCLKAESPEAALEIFNDSFESWIAHGFMCNKIFLLFCKQGKVDAATSFLKMMEQKGI
EPNVVFYNNMMLAHCRMKNMDLARSIFSEMLEKGLEPNNFTYSILIDGFFKNKDEQNAWD
VINQMNASNFEANEVIYNTIINGLCKVGQTSKAKEMLQNLIKEKRYSMSCTSYNSIIDGF
VKVGDTDSAVETYREMSENGKSPNVVTFTSLINGFCKSNRMDLALEMTHEMKSMELKLDL
PAYGALIDGFCKKNDMKTAYTLFSELPELGLMPNVSVYNSLISGFRNLGKMDAAIDLYKK
MVNDGISCDLFTYTTMIDGLLKDGNINLASDLYSELLDLGIVPDEILHMVLVNGLSKKGQ
FLKASKMLEEMKKKDVTPNVLLYSTVIAGHHREGNLNEAFRLHDEMLEKGIVHDDTVFNL
LVSGRVEKPPAASKISSLASPEMRSSY*